Biomet Hip Lawsuit: Bernstein Liebhard LLP Notes Issuance of New Order in Federal Biomet Hip Replacement Litigation
The Firm is actively filing Biomet hip replacement lawsuits on behalf of individuals who suffered hip implant failure, metallosis and other complications allegedly due to the Biomet M2a Magnum Hip Implant.
New York, New York (PRWEB) April 21, 2013
Biomet hip lawsuits involving the Biomet M2a Magnum hip implant continue to move forward in a multidistrict litigation now underway in U.S. District Court, Northern District of Indiana. According to a posting on the Court´s website, a new Order has been issued governing discovery of electronically-stored information. Additional court documents indicate that the next Case Management Conference in the Biomet hip replacement litigation will be held on Monday, April 22, 2013. (In re: Biomet M2a Magnum Hip Implant Products Liability Litigation — MDL No. 2391)
“We are pleased to see that discovery is continuing to move forward in the Biomet hip replacement litigation. Our firm continues to receive inquiries from Biomet M2a hip recipients who have allegedly suffered serious and debilitating complications related to the metal-on-metal device,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm is actively filing Biomet hip lawsuits in the federal multidistrict litigation, and continues to offer free legal evaluations to individuals allegedly injured by the Biomet M2a hip.
Biomet Hip Replacement Lawsuits
Biomet M2a Magnum Hip Replacements are metal-on-metal hip implants, which consist of a ball and cup made from a chromium-cobalt alloy. According to court documents, more than 140 Biomet hip replacement lawsuits have been filed in Indiana, all of which allege the metal-on-metal design can generate high levels of metal ions, leading to metallosis in the surrounding tissue and early failure of the device.
Metal-on-metal hip implants are a class of device currently being reviewed by the U.S. Food & Drug Administration (FDA). On January 17th, the FDA proposed an order requiring manufacturers of metal-on-metal total hip replacement systems to submit premarket approval (PMA) applications, which would make them ineligible for 510(k) clearance. The agency has also recommended that doctors consider metal ion testing for all-metal hip replacement patients who are experiencing symptoms of a failing implant, including pain, swelling, loosening of the implant, or change in the ability to walk.*
Individuals who have suffered metallosis, hip implant failure, and other serious complications as a result of a Biomet hip replacement may be entitled to compensation for their medical bills, lost wages, pain and suffering, and other damages. A wealth of information about Biomet hip lawsuits is available at Bernstein Liebhard´s website. For additional information, please contact one of our attorneys today by calling 1-877-779-1414.
About Bernstein Liebhard
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs´ Hot List,” recognizing the top plaintiffs´ firms in the country, for the past 10 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414 Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
For the original version on PRWeb visit: http://www.prweb.com/releases/prwebbiomet-hip-lawsuits/biomet-m2a-magnum-hip/prweb10654002.htm